They explored impaired Trx activity resulting from elevated plasma glucose levels linked to hyperglycemia, which are known to adversely affect endothelial cell function, and diminish responsiveness to vascular endothelial growth factor-A (VEGF-A). Here, VEGFA is linked to Hyperglycemia.